ArticleCellular oncology (Dordrecht, Netherlands)2018

In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells.

Claudia Busonero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.